These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 686735)

  • 1. Sabin's poliomyelitis vaccine in recurrent herpes simplex.
    Bierman SM
    Arch Dermatol; 1978 Jul; 114(7):1094-5. PubMed ID: 686735
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on the treatment of recurrent herpes simplex with poliomyelitis vaccine (Sabin's).
    Tager A
    Dermatologica; 1974; 149(4):253-5. PubMed ID: 4459181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of recurrent herpes simplex in medical personnel in a dermatology clinic using the trivalent poliomyelitis vaccine (Sabin)].
    Reich P; Stöcker W; Reich B
    Z Gesamte Hyg; 1985 Dec; 31(12):708-9. PubMed ID: 4096043
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decrease in the recurrence frequency of herpes simplex through poliomyelitis-serum prevention?].
    Ringwald E
    Dtsch Med Wochenschr; 1978 Jan; 103(4):175. PubMed ID: 624261
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recurrent herpes: treatment using trivalent oral polio vaccine (author's transl)].
    Garrel J; Millet P; Sonneck JM; Grossetete G; Tilles G
    Nouv Presse Med; 1979 Jan; 8(1):47. PubMed ID: 554064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sabin poliomyelitis vaccine in the treatment of recurrent herpes simplex].
    Tager A
    Harefuah; 1974 Apr; 86(7):363-5. PubMed ID: 4846049
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of recurring herpes simplex with poliovaccine].
    Haustein UF; Wiemers U
    Dermatol Monatsschr; 1980 Nov; 166(11):751-2. PubMed ID: 7461243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].
    Assumma M; Russo V; Alemanno A
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):175-86. PubMed ID: 5615073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autohistoradiographic investigations of the lymphatic and splenic localization of poliovirus, type 3, attenuated according to Sabin's method and labeled with I-131. (Experimental research)].
    Nigro N; Mussa GC; Mussa A
    Minerva Pediatr; 1966 Feb; 18(4):149-52. PubMed ID: 4286574
    [No Abstract]   [Full Text] [Related]  

  • 10. [The behavior of homologous and heterologous complement-fixing antibodies against poliomyelitis after oral vaccination with Sabin's live vaccine].
    Altevogt R
    Z Immunitatsforsch Allerg Klin Immunol; 1965 Sep; 129(3):296-301. PubMed ID: 4223286
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDY ON POLIOVIRUS INFECTIONS IN CHILDREN OF COLLECTIVES VACCINATED WITH SABIN'S LIVE VACCINE].
    CHAPURSKAIA NO; CHERNOVA Ia; KIRICHINSKAIA IO; BORODAI VM
    Pediatr Akus Ginekol; 1964; 4():30. PubMed ID: 14294012
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of oral poliovirus vaccine for unlicensed indications.
    CMAJ; 1991 Sep; 145(6):661. PubMed ID: 1893321
    [No Abstract]   [Full Text] [Related]  

  • 13. The trial use of Sabin's attenuated type 1 poliovirus vaccine in a village in southern Arizina.
    HORSTMANN DM; NIEDERMAN JC; RIORDAN JT; PAUL JR
    Am J Hyg; 1959 Sep; 70():169-84. PubMed ID: 14403223
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of recurrent genital herpes simplex with the Sabin triple vaccine].
    Macotela E; Alvarez-de la Rocha JB; Castillo-Rodríguez R; Suárez-de la Torre RS; Lugo-Dorantes A
    Gac Med Mex; 1979 Oct; 115(10):461-3. PubMed ID: 535681
    [No Abstract]   [Full Text] [Related]  

  • 15. Sabin's vaccine used for nonspecific prevention of infant diarrhea of viral etiology.
    Contreras G
    Bull Pan Am Health Organ; 1974; 8(2):123-32. PubMed ID: 4369156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the administration of Mexaform in the course of anti-poliomyelitis vaccination with Sabin's attenuated virus].
    Crovari P; Bori D
    Minerva Med; 1967 Apr; 58(33):1497-502. PubMed ID: 6026631
    [No Abstract]   [Full Text] [Related]  

  • 17. Some results of country-wide vaccinations against poliomyelitis with Sabin's attenuated strains in Hungary.
    DOMOK I
    Arch Gesamte Virusforsch; 1963; 13():98-103. PubMed ID: 14028547
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin's vaccine strain. I. Standardization and evaluation of the test.
    NAKANO JH; GELFAND HM
    Am J Hyg; 1962 May; 75():363-76. PubMed ID: 14478185
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurological complications after vaccination with Sabin's live poliomyelitis vaccine].
    SCHALTENBRAND G; SPULER H; HOPF HC
    Munch Med Wochenschr; 1962 Oct; 104():1917-24. PubMed ID: 13976666
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of the glutamic-oxalacetic and pyruvic transaminases in the course of Sabin's antipoliomyelitic vaccination].
    Monari E; Mei V
    Clin Pediatr (Bologna); 1966 Apr; 48(4):153-61. PubMed ID: 5961326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.